07.10.2021 | Letter to Editor
Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child
Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2022
Einloggen, um Zugang zu erhalten